INTRODUCTION

Cytotoxic CD8
+ T (Tc) cells and natural killer (NK) cells use death ligands, granule exocytosis, and soluble proinflammatory cytokines to combat intracellular pathogens and cell transformation (Biron, 1994; Russell and Ley, 2002) . Conventionally, granule exocytosis and death ligands exert this function by inducing target cell death; meanwhile, interferon g (IFNg) and tumor necrosis factor alpha (TNFa), among other cytokines, participate in the development of beneficial inflammatory responses by modulating the activity of macrophages and dendritic cells. However, if these pathways are not properly regulated, autoimmune and inflammatory disorders may develop. Granule exocytosis may be described as a specialized form of intracellular protein delivery. Here, a pore-forming protein perforin (perf) aids the translocation of a family of serine proteases (granzymes [gzms] ) into the cytosol of target cell (Voskoboinik et al., 2006) . The gzms are ultimately responsible for target cell death by activating various mechanisms that execute the offending cell. Among the described proteinases (five in humans and ten in mice), gzmA and gzmB are the most abundant and thoroughly characterized (Bovenschen and Kummer, 2010; Chowdhury and Lieberman, 2008; Grossman et al., 2003) . Whereas GzmB is clearly cytotoxic (Bleackley, 2005; Trapani and Sutton, 2003) , the supposition that gzmA only induces cell death is controversial (Lieberman, 2010; Metkar et al., 2008) . Gzms have been shown to inactivate viral particles, degrade extracellular matrix, and induce adherent cells to manufacture proinflammatory cytokines (Anthony et al., 2010a; Froelich et al., 2009; Hendel et al., 2010; Pardo et al., 2009; Romero and Andrade, 2008) . Specifically, gzmA, gzmK, and gzmM in vitro may promote the release of proinflammatory cytokines from macrophages and gzmB may enhance the proinflammatory activity of interleukin 1a (IL1a) (Afonina et al., 2011) . More compellingly, gzmA-or gzmM-deficient mice resist lipopolysaccharide (LPS)-induced septic shock (Anthony et al., 2010a; Metkar et al., 2008) , suggesting that gzmA and gzmM may contribute to the pathogenesis of bacterial sepsis.
Bacterial sepsis is presumed to be caused by uncontrolled production of proinflammatory cytokines (IL6, TNFa, and IL1b) secreted by macrophages (Angus and van der Poll, 2013) . This outcome depends upon a process where macrophages are overactivated by recognition of bacterial pathogen-associated molecular patterns (PAMPs). They are recognized by Toll-like receptors (TLRs) and other pattern recognition receptors in both plants and animals. Bacterial LPS, an endotoxin found on the bacterial cell membrane, is a prototypical PAMP (Van Amersfoort et al., 2003) . Endotoxin is a potent mediator of gram-negative bacteria-induced sepsis, but other bacterial components also contribute to the inflammatory response (e.g., peptidoglycan; Van Amersfoort et al., 2003) . Although macrophages are critical promoters of septic shock, other cell types likely contribute to this pathological outcome including Tc and NK cells (Sherwood et al., 2003) . Several studies have shown a positive correlation between the severity of sepsis and the expression of gzms A and B in lymphocytes (Schaer et al., 2006; Zeerleder et al., 2005) . Whether the contribution of perf and gzms to the pathology observed during sepsis is due to the induction of cell death or to proinflammatory effects is unknown (Hashimoto et al., 2000; Wesche-Soldato et al., 2007) .
Unfortunately, the animal model of sepsis induced by LPS does not fully recapitulate the many facets of the septic shock response (Rittirsch et al., 2007) . There is a need for animal models where the clinical signs of sepsis develop after exposure to endogenous bacterial pathogens. To test whether Tc/NK-cellderived gzms control a replicating pathogen as well as paradoxically contribute to sepsis, we have used Brucella microti, a newly described mouse pathogen. Brucella microti, a member of the Brucella genus isolated from wild rodents, is an intracellular facultative pathogen that replicates primarily in macrophages and, in contrast to other Brucella spp, produces systemic bacteremia and fatal sepsis (Jimé nez de Bagü é s et al., 2010 de Bagü é s et al., , 2011 .
RESULTS
Role of Cytolysis in the Control of Brucella microti Infection
Overall, we asked whether alteration in the levels of cytolytic components might curtail inflammation during sepsis without affecting control of the bacterial infection and, thus, could constitute a selective therapeutic approach. In contrast to Brucella spp, which are nontoxic for mice, inoculating wild-type (WT) C57Bl6 (B6) mice with 10 6 colony-forming units (cfu) of Brucella microti causes sepsis within 1 week (Alcaraz et al., 2010, Am. Coll. Vet. Pathol., conference; Jimé nez de Bagü é s et al., 2010). Thus, we applied a biological tool to study the control of bacterial sepsis in a mouse model. Brucella spp infect the host by varied routes including inhalation, inoculation through the conjunctival sac, ingestion of contaminated food, or through breaks in the skin. We chose intraperitoneal (i.p.) inoculation because this form of infection mimics entry through skin cuts (Turner et al., 2011 Figure 1A , right panel). Next, we examined the cytolytic pathways of Tc cells that might control infection in vivo by inoculating WT and various knockout (KO) mice with a sublethal cfu of B. microti and monitoring bacteria replication in spleen and liver. Compared to WT mice, bacterial clearance from the spleen ( Figure 1B , and gld mice. The time of maximum bacterial load (day 3) was similar among the animal groups. However, differences between WT and perf
, and gzmAxB À/À groups were noted at 7 days, the time when the WT animals began to clear infection. These differences then became more pronounced after 14 and 21 days. In the liver, the results were less dramatic; here, only perf À/À and perfxgzmAxB À/À mice showed higher cfu than WT mice. Finally, we found that the level of IFNg in serum was similar for WT, perfxgzmAxB
, gzmAxB À/À , and Fas À/À mice after 3 and 7 days ( Figure 1C ), suggesting that defects in perfxgzmAxB À/À and gzmAxB À/À mice were not due to the failure of these animals to respond to B. microti inoculation. Further supporting this possibility, isolated CD4 + and CD8 + T cells from WT and KO mice produced similar levels of IFNg after restimulation with Brucella antigens in vitro ( Figure 1D ). Figure S1 ). Expression of the granzymes was accompanied by an increase in the ability of the ex vivo WT Tc cells to inhibit B. microti replication in bonemarrow-derived macrophages (BMDM) ( Figure S2A ). Tc cells from noninfected mice were unable to inhibit B. microti replication, indicating that the observed effects were antigen specific ( Figure S2B ). We then compared the ability of Tc cells from WT, perfxgzmAxB
Tc
, gzmAxB À/À , and gld mice to control B. microti replication in BMDMs. Bacterial growth was less reduced for Tc cells lacking perf or gzmB compared to WT or gzmA-deficient Tc cells ( Figure 2A ). To directly test in our model that Tc control B. microti growth, we presumed that Tc cells containing perf and gzmB would reduce bacterial proliferation by eliminating infected BMDMs. Thus, in parallel experiments described for Figure 2A , we tested whether B.-microti-infected macrophages were killed by Tc cells containing perf and gzmB. Whereas B. microti was not toxic ( Figure 2B ). The levels of apoptosis induced by Brucella-specific Tc cells against infected BMDMs was similar to lymphocytic choriomeningitis virus (LCMV)-specific Tc cells against noninfected, gp33-pulsed BMDMs, indicating a high level of Tc cell activation during B. microti infection. Supporting a role for macrophage apoptosis in the control of bacterial replication, we found that the number of bacteria in macrophages treated with the protein kinase C inhibitor staurosporine was significantly lower than the untreated controls after 24 hr ( Figure S3A ). This outcome was observed for cells incubated with staurosporine for 24 hr, although apoptosis was evident after 7 hr ( Figure S3C ). Because B. microti starts to replicate in BMDM after 7 hr (data not shown), this finding suggests that apoptosis per se does not kill the bacteria but inhibits replication in the cells undergoing apoptosis. Supporting this possibility, if these macrophages (infected for 7 hr in vitro) acted as the source of B. microti for infection in vivo, a significantly lower level of infection was observed compared to viable infected BMDM ( Figure S3B ). Altogether, these experiments suggest that perf and gzmB indeed control B. microti replication by inducing apoptosis in cells that harbor the pathogen. , and perfxgzmAxB À/À mice were inoculated with 10 6 cfu of B. microti, and survival was monitored for 21 days. Approximately 60% of WT, gzmB À/À , perf À/À , and perfxgzmAxB À/À mice died during the first 10 days ( Figure 3A ). In contrast, gzmA-deficient animals were spared (20% died). Remarkably, if mice received a highly lethal dose (10 7 cfu), all WT animals died in 7 days, whereas 20% of gzmA À/À mice survived (data not shown). These data indicate that inflammation induced by gzmA contributes to septic response induced by B. microti infection and provides biologically relevant confirmation that gzmA deficiency protects mice from LPS-induced septic shock (Anthony et al., 2010b; Metkar et al., 2008) . We cannot conclude if this effect depends on the presence of perf. Here, both perf
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and perfxgzmAxB À/À mice were just as susceptible as WT mice to sepsis whereas bacteremia was significantly higher in perfxgzmAxB À/À than gzmA À/À mice ( Figure S4 ). Emphasizing that the lethal effect of Brucella was TLR-dependent, TLR4
À/À mice survival was significantly greater than for WT animals ( Figure 3 ). During sepsis, bacteria circulate throughout the vasculature, disseminating in multiple organs. Accordingly, B. microti was identified in blood, liver, spleen, brain, kidney, and lung 3 days after receiving a lethal dose inoculation ( Figure 3B ). Again, no difference was observed between WT and gzmA À/À mice.
DIC is a catastrophic complication of sepsis. Accordingly, the improved survival of gzmA-deficient mice was associated with a reduction in DIC ( Figure 3C ). After inoculation with 10 6 cfu of B. microti, gzmA À/À mice had lower prothrombin times and higher platelet counts than WT mice. The level of serum alanine aminotransferase (ALT) was also lower in gzmA À/À mice, although the values did not reach statistical significance. Finally, to verify that protection was partially due to reduced serum level of proinflammatory cytokines, we monitored the concentrations of IL1a, IL1b, TNFa, IL6, IFNg, and MIP1a in WT and gzmA À/À mice during the 72 hr after lethal bacterial inoculation. Compared to levels observed in mice receiving a nonlethal dose (10 5 cfu), mice that received 10 6 cfu had significantly higher level of cytokines (Table S1 ). When cytokine levels were measured in animals infected with 10 6 cfu, the concentration of all cytokines except IFNg was significantly lower in gzmA À/À than in WT animals ( Figure 3D ). with B. microti (10 5 cfu) and the number of cfu in liver and spleen at 7 and 14 days was quantified. Data are mean ± SEM of the indicated number of biological replicates performed in two independent experiments; *p < 0.05; **p < 0.01; ***p < 0.001, comparing each group with the control group (Iso IgG). In parallel (right panels), splenocytes were isolated from three animals of each group, stained with CD3/CD8, CD11b/CD11c, and NK1. induced by gzmA would be executed by NK cells from the innate arm of the immune system. We analyzed the survival of mice in which NK cells were depleted after inoculation with a lethal dose. After depletion of NK cells, 78% of mice survived bacterial sepsis compared to 27% of mice treated with control immunoglobulin G (IgG) ( Figure 4A ). However, NK cell depletion did not alter bacterial clearance in spleens of surviving mice ( Figure 4B ). In addition, NK cells isolated from mice infected with a lethal dose of B. microti expressed gzmA ( Figure 4C ). mice. Subsequently, mice were challenged with 10 6 cfu B. microti and survival was monitored. Survival of gzmA-deficient mice was significantly higher than WT mice ( Figure 4D) . Notably, the survival of gzmA-deficient mice in which WT NK cells had been transferred was now similar to WT mice; meanwhile, transfer of gzmA-deficient NK cells did not alter the susceptibility to sepsis of gzmA À/À mice. These data strongly confirm that gzmA associated with NK cells are regulating the septic response during infection with the mouse bacterial pathogen B. microti.
DISCUSSION
The genesis of septic shock remains poorly understood and has resisted treatment with a variety of therapeutics (Angus and van der Poll, 2013) . Recent efforts have focused on alterations within the immune system to identify treatment options (Chiche et al., 2011) . A major drawback in dissecting the innumerable steps that culminate in sepsis has been the relative lack of animal models to study this major health problem. We have employed a mouse gram-negative bacterial pathogen, B. microti, to analyze the capacity of Tc and NK cells to control bacterial infection as well as contribute to the development of sepsis. Our data show that WT mice Tc cells participate in the control of B. microti infection in vivo and in vitro with the aid of perf and gzmB. However, other forms of immunity likely contribute to bacterial clearance because mice marginally reduce bacterial replication despite the absence of Tc cells or perf and gzmB. In marked contrast, gzmA contributes to the increased proinflammatory cytokine response during sepsis, a process that depends on the presence of NK cells.
What is the mechanism underlying the control of B. microti by perf and gzmB, and why would gzmA be dispensable? Unlike tumor models, understanding the immune etiopathogenesis of a pathogen that survives in macrophages is more complicated. For example, perf and gzmB certainly could kill an infected macrophage; however, Brucella-filled apoptotic bodies would be engulfed by adjacent macrophages allowing the bacteria to have a replicative advantage. Here, the inflammatory microenvironment would be predicted to enhance the capacity of bystander macrophage to kill these infected apoptotic bodies, a function served by gzmA. Inasmuch as gzmA induces cytokines that would augment the bactericidal activity of monocyte-macrophages, it is unclear why the protease does not aid clearance of the pathogen. Our data do not unequivocally discount a protective role for gzmA in the immune response against B. microti but suggest that other cell types that do not respond to gzmA may be bacterial reservoirs. Finally, the phagocytosis of infected apoptotic cells by bystander dendritic cells would enable cross priming of T cells enhancing the elimination of pathogens, a scenario that has been reported for Salmonella (Yrlid and Wick, 2000) and Mycobacterium tuberculosis (Schaible et al., 2003) . However, these pathways have not been examined in the control of Brucella spp.
GzmA deficiency appears to dramatically protect mice from sepsis during B. microti infection. A similar safeguard occurs after NK cell depletion, suggesting that NK cells are the source of proinflammatory gzmA during bacterial sepsis. Confirming this possibility, the transfer of NK cells from WT mice into gzmA À/À mice enhances the susceptibility of mice to a septic response comparable to WT mice. The results reported here directly corroborate our recent observation that gzmA deficiency increases the resistance of mice to septic shock induced by LPS (Metkar et al., 2008) , a finding confirmed by others (Anthony et al., 2010b) . Nevertheless, these studies did not clarify whether the resistance of the gzmA KO mice was related to the amelioration of the cytokine storm induced by LPS because the serum levels of proinflammatory cytokines were not monitored. Until now, whether gzmA is indeed a physiological modulator of inflammation has been controversial. Furthermore, to maintain the homeostatic milieu, the immune system must balance the proinflammatory response necessary to control a bacterial infection without inducing immunopathology.
Recent evidence suggests that several gzms including gzmA, gzmB, and gzmK possess perf-independent extracellular functions that could influence hemostasis, vascular permeability, and other events that are considered hallmarks of sepsis (Hendel et al., 2010; Hiebert and Granville, 2012) . Because perf À/À and perfxgzmAxB À/À mice are equally susceptible to sepsis as WT mice, we are unable to determine whether the participation of gzmA occurs intra-or extracellularly. In comparison, perf deficiency has been reported to protect mice from sepsis induced by LPS (Anthony et al., 2010b) . Addressing this conflict, perf deficiency clearly increases the replication of B. microti ( Figure S4 ). Thus, the beneficial ''anti-inflammatory'' effect in mice lacking both perf and gzmA is likely reduced by the higher bacterial load observed in these animals in comparison with animals that lack only gzmA. Our data indicate that inflammation induced by gzmA in vivo plays a critical role in the development of sepsis associated with B. microti infection. Indeed, the absence of gzmA substantially protects mice from the lethal effects of B. microti where survival correlated inversely with serum levels of IL6, TNFa, IL1a, IL1b, and MIP1a. Importantly, IFNg, the only cytokine that is present at similar levels in both WT and gzmA KO mice, is not produced by macrophages and thus is predicted to be unaffected by gzmA. Thus, the reduced level of cytokines in the absence of gzmA is likely due to the lack of protease-mediated induction of proinflammatory responses in macrophages, which are considered a major source of these cytokines during bacterial infections (Benoit et al., 2008) . The reduction in the inflammatory response could also explain the amelioration of DIC parameters observed in gzmA-deficient mice, because it has been reported that inflammatory cytokines like IL1a/ILb, IL6, or TNFa contribute to the activation of the coagulation cascade by enhancing the production of tissue factor and decreasing the expression of anticoagulation factors (van der Poll et al., 2000) . Alternatively, it has been described that both gzmA and gzmK, which express similar cleavage specificity as gzmA, are able to activate the protease-activated receptors (PAR) in neurons and fibroblasts (Cooper et al., 2011; Suidan et al., 1994) . These receptors are involved in platelet activation and thrombosis upon activation by thrombin, and accordingly, one could speculate that extracellular gzmA may directly promote thrombosis. However, it is not clear if gzmA-mediated PAR activation in platelets is sufficient to promote platelet aggregation (Suidan et al., 1996) , and thus, this hypothesis requires further research.
How does a protease from NK cells regulate macrophage function? Various studies have established that macrophage/NK cell crosstalk occurs during bacterial infections (Hamerman et al., 2004; Nedvetzki et al., 2007) , probably due to the interaction of NK-associated TLR ligands with macrophage-associated receptors. Notably, it has been reported that LPS stimulates the expression of the activating NKG2D ligand MicA on macrophages through a TLR-dependent mechanism (Eissmann et al., 2010) . Ligation of NKG2D would stimulate the secretion of cytotoxic granule toward the interacting macrophage where the protease then modulates macrophage activity.
We have shown that two members (gzmB and gzmA) expressed by Tc and NK cells differentially contribute bacterial immunopathogenesis. By targeting gzmA, one may ameliorate bacteria-associated sepsis without compromising the ability of the immune system to control infection. This finding opens the possibility of treating inflammatory sepsis without causing immunosuppression. ), and gld (FasL mutant) bred on the B6 background and inbred C57BL/10 and a mouse strain with a spontaneous mutation for TLR4 were provided by Markus Simon and Marina Freudenberg (TLR4) from the Max-Planck-Institut fü r Immunbiologie, Freiburg and bred at the Centro de Investigació n y Tecnología Agroalimentaria (CITA). Their genotypes were periodically analyzed as described . Mice of 8-12 weeks of age were used in all experiments.
Bacterial Strain and Determination of cfu B. microti strain CCM4915 was grown to stationary phase in tryptic soy broth (Difco Laboratories), with shaking, at 37 C for 24 hr. The number of living bacteria in a sample was determined by counting the cfu after plating serial dilutions onto tryptic soy agar plates as described previously (Jimé nez de Bagü é s et al., 2011). In addition, the smooth phenotype of the strains was verified in all cases by crystal violet staining (Jimé nez de Bagü é s et al., 2010).
Replication of Brucella microti In Vivo
A sublethal dose (10 5 cfu) of B. microti was injected intraperitoneally, and after different time points, the mice were euthanized by CO2 asphyxiation and blood, spleen, and liver samples were collected aseptically. The spleen and liver were weighed, homogenized, serially diluted, and plated onto tryptic soy agar for culture and counting of viable Brucella organisms after 24 to 48 hr of growth at 37 C.
In Vivo Depletion of NK and CD8 + T Cells
Depletion of NK and CD8 + T cells was performed using the rat anti-NK1.1 monoclonal antibody (mAb) pk136 and an anti-mouse CD8a mAb (53-6.72), respectively, as indicated in Supplemental Experimental Procedures.
Replication of Brucella microti in BMDM In Vitro Macrophages were differentiated from mouse bone marrow during 6 days as described previously (Aporta et al., 2012) and in Supplemental Experimental Procedures. For replication experiments in vitro, 4 3 10 5 macrophages/well were seeded in 24-well plates and infected with B. microti at a multiplicity of infection of 25:1 for 45 min at 37 C, 5% CO2. At this time point, in some experiments, staurosporine (500 nM) or MACS-enriched (positive selection; Miltenyi Biotec) splenic Tc or NK cells from WT or KO mice were added. Subsequently, medium was removed and cells were washed with PBS and further incubated with Dulbecco's modified Eagle's medium 10% fetal calf serum containing 30 mg/ml of gentamycin. After 24 hr, macrophages were lysed with Triton X-100 0.1%, and cfu number was determined.
Flow Cytometry
Intracellular expression of granzymes and IFNg were analyzed by FACS as previously described (Joeckel et al., 2011 ; see the Supplemental Experimental Procedures for more details). Cytotoxicity Assay Tc cells were isolated from mouse spleen using MACS-positive selection (Miltenyi Biotec) and used for cytotoxic analyses on target cells as previously described ; see the Supplemental Experimental Procedures for more details).
Evaluation of Sepsis Induced by Brucella microti Infection B6, KO, and NK-depleted mice were infected with 10 6 cfu (lethal dose in B6 mice) of B. microti, and mouse survival was monitored during 21 days. In addition, some mice were sacrificed after 6, 12, 24, and 72 hr of infection, and IL1a, IL1b, IL6, IFNg, TNFa, and MIP1a levels in serum (Multiplex Bead Array System; Luminex; Millipore) or prothrombin time, platelet counts, and ALT levels in plasma were analyzed.
Statistical Analyses
Statistical analysis was performed using GraphPad Prism software. The difference between means of paired or unpaired samples was performed using the respective t test. Survival curves were compared using both the log rank test and the Gehan-Wilcoxon test. The results are given as the confidence interval (p) and are considered significant when p < 0.05. Biological replicates are considered as the number of individual mice. A., M.M.S., and C.J.F. provided experimental advice and wrote the paper. J.P. conceived and designed the study, supervised the project, and wrote the paper.
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